Who has invested in CARsgen Therapeutics?

Photon Fund, DAOL Investment, BioVeda China Fund are named among the investors backing CARsgen Therapeutics.

CARsgen Therapeutics Funding: $276M Raised, IPO (2020)

CARsgen Therapeutics funding overview

CARsgen Therapeutics is based in Shanghai, China. CARsgen Therapeutics has raised $276M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in November 2020. The round record for CARsgen Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Photon Fund, DAOL Investment, BioVeda China Fund. 3 distinct backers are named across the disclosed rounds.

CARsgen Therapeutics at a glance

Total raised: $276M
Latest round: IPO
Latest round date: November 2020
Headquarters: Shanghai, China
Notable investors: Photon Fund, DAOL Investment, BioVeda China Fund

Frequently asked about CARsgen Therapeutics funding

How much has CARsgen Therapeutics raised?: CARsgen Therapeutics has raised $276M in total disclosed funding across the rounds on record.
Who has invested in CARsgen Therapeutics?: Photon Fund, DAOL Investment, BioVeda China Fund are named among the investors backing CARsgen Therapeutics.
What was the latest CARsgen Therapeutics funding round?: The most recent disclosed round is an IPO, announced in November 2020.
Where is CARsgen Therapeutics based?: CARsgen Therapeutics is based in Shanghai, China.
When did CARsgen Therapeutics last raise?: The last disclosed CARsgen Therapeutics round closed in November 2020 at IPO.

Every CARsgen Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.

CARsgen Therapeutics Funding: $276M Raised, IPO (2020)

CARsgen Therapeutics funding overview

CARsgen Therapeutics at a glance

Frequently asked about CARsgen Therapeutics funding

Companies related to CARsgen Therapeutics (18)

Browse related funding lists (5)